www.fdanews.com/articles/149154-u-s-approves-spectrum-pharma-rsquo-s-purchase-of-allos
U.S. Approves Spectrum Pharma’s Purchase of Allos
September 4, 2012
U.S. antitrust officials have approved Spectrum Pharmaceuticals’ purchase of cancer drugmaker Allos Therapeutics, a $206 million deal aimed at giving Spectrum access to the Allos anti-cancer drug Folotyn.
Reuters
Reuters